Anti-hepatitis B virus activity of new 1,2,4-triazol-2-yl- and 1,3,4-oxadiazol-2-yl-2-pyridinone derivatives

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 63, Issue 9-10, 2008, Pages 667-674

  El Essawy, Farag A ^a   El Sayed, Wael A ^b   El Kafrawy, Sherif A ^c   Morshedy, Asmaa S ^a   Abdel Rahman, Adel H ^a  

^a Menoufia University   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

1,2,4 triazoles; 1,3,4 oxadiazoles; Anti hepatitis B virus

Indexed keywords

HEPATITIS B VIRUS;

EID: 56249131101     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2008-9-1010     Document Type: Article

References (32)

1. Abdel Aal M. T., El Sayed W. A., Abdel Aleem A. H., and El Ashry E. S. H. (2003), Synthesis of some functionalized arylaminomethyl-1,2,4-triazoles, 1,3,4-oxa-and thiadiazoles. Pharmazie 58, 788-792.
2. Ali A. E., Omar A. A., Mohamed A. O., and Johen L. (2004), Synthesis, antimicrobial and anti-HIV-1 activity of certain 5-(1-admantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-admantyl)-3-substituted aminomethyl-1,3,4- oxadiazoline-2-thiones. Bioorg. Med. Chem. Lett. 12, 5107-5113.
3. Al-Soud Y. A., Al-Dweri M. N., and Al-Masoudi N. A. (2004), Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Farmaco 59, 775-783.
4. Amir M. and Shikha K. (2004) Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6- dichloroanilino)-phenyl]acetic acid derivatives. Eur. J. Med. Chem. 39, 535-545.
5. Awad L. F. and El Ashry E. S. H. (1998), Synthesis and conformational analysis of seco C-nucleosides and their diseco double-headed analogues of the 1,2,4-triazole, 1,2,4-triazolo[3,4-b]1,3,4-thiadiazole. Carbohydr. Res. 312, 9-22.
6. Bernan T. M., Taylor D. L., Bridges C. G., Leyda J. P., and Tyms A. S. (1995) The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds. Antiviral Res. 26, 173-187.
7. Birsen T., Esra K. P. E., and Mevlu T. E. (2007), Preparation of 5-aryl-3-alkylthio-1,2,4-triazoles and corresponding sulfones with antiinflammatory-analgesic activity. Bioorg. Med. Chem. 15, 1808-1814.
8. Colanceska-Ragenovic K., Dimova V., Kakurinov V., Molnar D. G., and Buzarovska A. (2001), Synthesis, antibacterial and antifungal activity of 4-substituted-5-aryl-1,2,4-triazoles. Molecules 6, 815-824.
9. Demirbas N., Alpay Karaoglu S., Demirbas A., and Sancak K. (2004), Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4] thiadiazol-2-yl)-methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4] triazol-3-yl)methyl-5-oxo-[1,2,4]triazole derivatives. Eur. J. Med. Chem. 39, 793-804.
10. El-Azzouny A. A., Maklad Y. A., Bartsch H., Zaghary W. A., Ibrahim W. M., and Mohamed M. S. (2003), Synthesis and pharmacological evaluation of fenamate analogues: 1,3,4-oxadiazol-2-ones and 1,3,4-oxadiazole-2-thiones. Sci. Pharm. 71, 331-356.
11. El-Essawy F. and Khattab A. F. (2004), Alkylation of 2-pyridinones: Synthesis of novel acyclonucleosides. J. Het. Chem. 41, 311-316.
12. Foroumadi A., Mirzaei M., and Shafiee A. (2001), Anti-tuberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Farmaco 56, 621-623.
13. Fouad T., Nielsen C., Brunn L., and Pederson E. B. (1998), Use of standardization cell culture assay to assess activities of some potent anti-HIV nucleoside analogues against hepatitis B virus replication. Sc. J. Az. Med. Fac. (GIRLS) 19, 1173-1187.
14. Grover G. and Kini S. G. (2003), Synthesis and evaluation of new 1,3,4-oxadiazoles and 1,3,4-oxadiazole-2-thione derivatives of nalidixic acid as potential anti-bacterial and antifungal agents. Ind. J. Het. Chem. 12, 289-290.
15. Hassan Khan M. T., Choudhary M. I., Mohammed Khan K., Rani M., and Atta-ur-Rahman (2005), Structure-activity relationship of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues. Bioorg. Med. Chem. Lett. 13, 3385-3395.
16. Holla B. S., Poorjary K. N., Rao B. S., and Shivananda M. K. (2002), New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. Eur. J. Med. Chem. 37, 511-517.
17. Karabasanagouda T., Airody V. A., and Suchetha N. S. (2007), Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4- thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties. Eur. J. Med. Chem. 42, 521-529.
18. Korba B. E. and Gerin J. L. (1992), Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Res. 19, 55-70.
19. Labanauskas L., Udrenaite E., Gaidelis P., and Bruktus A. (2004), Synthesis of 5-(2-, 3- and 4-methoxy-phenyl)-4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity. Farmaco 59, 255-259.
20. Larson A., Alenius S., Johnsson N. G., and Oberg B. (1983), Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res. 3, 77-86.
21. Loetchutinat C., Chau F., and Mankhetkorn S. (2003), Synthesis and evaluation of 5-aryl-3-(4-hydroxyphenyl)-1,3,4-oxadiazole-2-(3H)-thiones as P-glycoprotein inhibitors. Chem. Pharm Bull. 51, 728-730.
22. Lokanatha Rai K. M. and Linganna N. (2000), Synthesis and evaluation of antimitotic activity of alkylated 2-amino-1,3,4-oxadiazole derivatives. Farmaco 55, 389-392.
23. Miyasaka T., Tanaka H., Baba M., Hayakawa H., Walker R. T., Balzarini J., and De Clercq E. (1989), A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J. Med. Chem. 32, 2507-2509.
24. Palaska E., Sahin G., Kelicen P., Durlu N. T., and Altmok G. (2002), Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 57, 101-107.
25. Sidwell R. W., Huffman J. H., Khare G. P., Allen L. B., Witkowski J. T., and Robins R. K. (1972), Broad-spectrum antiviral activity of virazole: 1. Beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177, 705-708.
26. Swamy S. N., Basappa B. S., Prabhuswamy P. B., Doreswamy B. H., Prasad J. S., and Rangappa K. S. (2006), Synthesis of pharmaceutically important condensed heterocyclic 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivatives as antimicrobials. Eur. J. Med. Chem. 41, 531-538.
27. Uberla K., Stahl-Hennig C., Bottiger D., Matz-Rensing K., and Kaup F. (1995), Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA 92, 8210-8214.
28. Varvarasou A., Sistra-Papastaikoud T., Tsantili-Kakoulidou A., and Vamvakides A. (1998), Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4-thiadiazole and 1,2,4-triazole. Farmaco 53, 320-326.
29. Venkatachalam T. K., Mao C., and Uckun F. M. (2004), Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds. Bioorg. Med. Chem. 12, 4275-4284.
30. Vinod M., Keshavayya J., Vaidya V. P., and Giles D. (2007), Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3, 4-b]-1,3,4-thiadiazoles and their dihydro analogues. Eur. J. Med. Chem. 42, 823-840.
31. Zareen A., Maimoona R., Choudhary M. I., Supino R., Khan Khalid M., and Atta-ur-Rahman (2004), Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles. Biophys. Res. Commun. 319, 1053-1063.
32. Zhang Z Y. and Sun X. W. (1998), s-Triazolo[3,4-b]-1,3,4- thiadiazole derivatives. Heterocycles 48, 561-584.